Skip to main content
Premium Trial:

Request an Annual Quote

Congress Boosts NIH Funding to $37.1B in New Spending Bill

NEW YORK (GenomeWeb) – Congressional leaders last night released a spending bill that includes a $3 billion increase in funding for the National Institutes of Health, bringing the agency's fiscal year 2018 budget to $37.1 billion.

The omnibus appropriations bill includes increases for every NIH institute and center, and specifically earmarks $1.8 billion for Alzheimer's disease research, a $414 million increase over FY2017; $400 million for the BRAIN Initiative, a $140 million increase over last year; and $290 million for the All of Us precision medicine initiative, a $60 million boost over the previous year.

While President Donald Trump has repeatedly sought to cut the NIH's budget, increasing investment in the agency has been a priority in recent years for both Republicans and Democrats in Congress.

"The previous two funding increases for the National Institutes of Health have fundamentally changed the prospects of scientists looking to treat and cure the most costly and deadly diseases impacting millions of Americans," Senator Roy Blunt (R-Mo.), chairman of the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, said in a statement. "This year's increase will further that progress and advance our goal of maintaining a pattern of sustained increases for medical research."

The spending bill, which would fund the government until the end of the end of the fiscal year on Sept. 30, also provides $5.1 billion to the US Food and Drug Administration — $483 million more than FY2017 — and includes $996 million in 21st Century Cures Act funding.

The full House and Senate have until March 23 to pass the appropriations measure, which is expected to be signed by President Trump.

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.